In September 2020, the company partnered with RDIF to conduct the clinical trials of Sputnik V and distribute the vaccine in India. The Hyderabad-based drug major has already stated that the locally manufactured Sputnik V will be available from September-October period.
Dr Reddy s recalls 2,980 bottles of cholesterol-lowering drug in US
Premium
The drug is also prescribed to lower the risk of heart attack and stroke in patients with cardiovascular diseases
2 min read
. Updated: 06 Jun 2021, 03:24 PM IST PTI
Atorvastatin is indicated to lower cholesterol in the blood for adults and children over ten years of age
Read Full Story
New Delhi: Drug major Dr Reddy s Laboratories is recalling 2,980 bottles of Atorvastatin Calcium tablets in the US due to quality issues.
Atorvastatin is indicated to lower cholesterol in the blood for adults and children over ten years of age.
MORE FROM THIS SECTIONSee All
Dr Reddy s recalls 2,980 bottles of cholesterol lowering drug in US
SECTIONS
Last Updated: Jun 06, 2021, 03:15 PM IST
Share
Synopsis
As per the US Food and Drug Administration s latest Enforcement report, the Hyderabad-based drug major is voluntarily recalling the affected lots of the drug in 10 mg strength due to failed impurities degradation specifications .
Agencies
The US-based unit of the drug major initiated the nationwide recall on February 19, 2021, and the USFDA has categorised it as Class III recall.
Drug major Dr Reddy s Laboratories is recalling 2,980 bottles of Atorvastatin Calcium tablets in the US due to quality issues. Atorvastatin is indicated to lower cholesterol in the blood for adults and children over ten years of age.
After opening on a flat note, the 30-share BSE index was trading 59.24 points or 0.11 per cent higher at 52,291.67 in initial deals, and the broader NSE Nifty advanced 16.85 points or 0.11 per cent to 15,707.2